Smart Evaporator from BioChromato Improves Lab Productivity
The benchtop device provides a sample preparation tool for labs in need of solvent removal directly from liquid chromatography vials or concentration of multiple samples from extraction or fractionation processes.
The BioChromato Smart Evaporator C10 from BioChromato, launched in February 2021, uses Vacuum Vortex Concentration technology to evaporate up to 10 samples in vials in parallel, thus improving lab productivity. Available in four colors, the benchtop device provides a sample preparation tool for labs in need of solvent removal directly from liquid chromatography vials or concentration of multiple samples from extraction or fractionation processes.
Additionally, the Smart Evaporator C10 features safe drying of temperature sensitive compounds, drying of solvent volumes as low as 0.1ml, and drying of samples without solvent bumping or splashing, removing the risk of sample loss and contamination, the company said in a Feb. 10, 2021 press release.
Source: BioChromato
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
